Helliwell, P., Coates, L., Fitzgerald, O., Nash, P., Soriano, E., Husni, M., . . . Kudlacz, E. (2018). Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease. BioMed Central.
Chicago-referens (17:e uppl.)Helliwell, P., et al. Disease-specific Composite Measures for Psoriatic Arthritis Are Highly Responsive to a Janus Kinase Inhibitor Treatment That Targets Multiple Domains of Disease. BioMed Central, 2018.
MLA-referens (9:e uppl.)Helliwell, P., et al. Disease-specific Composite Measures for Psoriatic Arthritis Are Highly Responsive to a Janus Kinase Inhibitor Treatment That Targets Multiple Domains of Disease. BioMed Central, 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.